Chapter VI.3. Problems

  1. Nawab Qizilbash MBChB, MRCP, MSc, DPhil (Oxon)1,2
  1. D. P. Devanand,
  2. Gregory H. Pelton,
  3. Steven P. Roose,
  4. Brian A. Lawlor,
  5. Gregory Swanwick,
  6. Pierre Tariot and
  7. Joan M. Swearer

Published Online: 14 JAN 2008

DOI: 10.1002/9780470752340.ch42

Evidence-based Dementia Practice

Evidence-based Dementia Practice

How to Cite

Devanand, D. P., Pelton, G. H., Roose, S. P., Lawlor, B. A., Swanwick, G., Tariot, P. and Swearer, J. M. (2003) Problems, in Evidence-based Dementia Practice (ed N. Qizilbash), Blackwell Science Ltd, Oxford, UK. doi: 10.1002/9780470752340.ch42

Editor Information

  1. 1

    Visiting Professor of Geriatric Medicine, Hospital Universitario GM-Cantoblanco, 280049 Madrid, Spain

  2. 2

    Member of Green College, Oxford University, Oxford, UK

Publication History

  1. Published Online: 14 JAN 2008
  2. Published Print: 1 JAN 2003

ISBN Information

Print ISBN: 9780632052967

Online ISBN: 9780470752340

SEARCH

Keywords:

  • problems;
  • norepinephrine;
  • dopamine;
  • antidepressant;
  • placebo

Summary

This chapter contains section titled:

  • Rationale

  • Who should be considered for treatment?

  • Adverse effects

  • Starting, stopping and monitoring treatment

  • Number needed to treat

  • Future research

  • Summary of evidence

  • Summary of interventions for depression

  • Psychosis

  • Conventional antipsychotics

  • Atypical antipsychotics

  • Prevalence of hypersexuality in dementia

  • Management of hypersexuality in dementia

  • Comment

  • Prevalence of insomnia

  • Treatment of insomnia in dementia

  • Conclusions